ETC-05

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameETC-05
Drug Alias NameETC-05
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsUterine Cervical Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEndocrine Technology LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEndocrine Technology LLC
Active IndicationsN/A
Inactive IndicationsUterine Cervical Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A